New Key Statistics Module, Z-Score and F-Score
NAS:URGN Key Ratios
| Market Cap $ M | 472.22 |
| Enterprise Value $ M | 422.73 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 4.47 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 82.00 |
| EPS (TTM) $ | -3.67 |
| Beneish M-Score | -2.06 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 9.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.06 |
| EV-to-EBITDA | -5.16 |
| PEG | -- |
| Shares Outstanding M | 36.13 |
| Net Margin (%) | -123.61 |
| Operating Margin % | -79.23 |
| Pre-tax Margin (%) | -118.87 |
| Quick Ratio | 5.24 |
| Current Ratio | 5.42 |
| ROA % (ttm) | -71.41 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -238.89 |
| Dividend Yield % | -- |
| Altman Z-Score | -4.35 |
URGN Number of Guru Trades
URGN Volume of Guru Trades
Gurus Latest Trades with NAS:URGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:URGN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
UroGen Pharma Ltd Insider Transactions
No Available Data
News about NAS:URGN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers